Design of SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
B. Tan, X. Zhang, A. Ansari, P. Jadhav, H. Tan, K. Li, A. Chopra, A. Ford, X. Chi, F. R. Figueras, E. Arnold, X. Deng, J. Wang
The paper designs SARS-CoV-2 PLpro inhibitors that show antiviral efficacy in a mouse model against SARS-CoV-2 and its variants.
bioRxiv · Dec 1, 2023Microbiology